Day 1 – Tuesday, 16 September 2025Tuesday, September 16, 2025 - ET (Eastern Time, GMT-05:00)

While the excitement and anticipation is huge, what is the actual way forward with AI? How are pharma companies using and leveraging AI to deliver commercial and patient benefits?

• How is pharma moving from AI hype to practical implementation?
• Highlighting examples of how pharma companies are currently leveraging AI to improve patient care and treatment efficacy
• Exploring how AI is being utilized to enhance commercial strategies, streamline processes, and drive revenue growth
• Discussing the critical factors pharma companies must address to ensure effective and sustainable AI adoption

Step into the future of pharma innovation. This open format discussion with industry leaders will illuminate the groundbreaking technologies poised to revolutionize the industry. But there’s a catch, we won’t be talking about AI! From the power of digital tech in drug discovery to the transformative potential of personalized medicine, we'll explore how emerging digital technologies are reshaping patient care, clinical trials, and the entire pharma landscape. Discover the cutting-edge advancements that will define the next era of pharmaceutical excellence.

Get the inside scoop on how pharma giants are leveraging strategic acquisitions and integrations to fuel unprecedented growth. We'll dissect the latest trends, reveal the critical factors for evaluating potential partners, and provide actionable strategies for navigating the complex world of pharma business development.

• Overview of the current landscape of pharma digital tech acquisitions and integrations – where is Pharma’s appetite?
• Assessing potential partners, ensuring strategic alignment and maximizing ROI
• Strategies for overcoming the hurdles of integrating acquired technologies – Are we there yet?
• Leveraging tech acquisitions for accelerated growth and competitive advantage in the pharma industry

Dive into the dynamic world of pharma tech investment. This panel brings together leading corporate VC’s to dissect the latest trends, analyze ROI potential, and explore the unique opportunities and challenges of funding groundbreaking pharmaceutical technologies. Discover how smart money is fuelling the future of medicine and learn the strategies for navigating this rapidly evolving and high-stakes landscape.

• Exploring the investment trends in the pharma tech space – what is the ROI?
• Discussing the role of corporate venture capital in funding pharma tech innovation
• Analysing the opportunities and challenges for investors in the rapidly evolving pharma tech landscape

The convergence of technology and biology is ushering in a new era of pharmaceutical innovation. This panel explores the dynamic partnership between TechBio startups and established pharma companies, examining how their combined expertise is revolutionizing drug discovery, development, and delivery. Discover the groundbreaking approaches that are shaping the next generation of therapeutics.

• Examining how AI, machine learning, and computational biology are accelerating target identification, drug design, and clinical trial optimization
• Exploring successful partnership and collaborative models for TechBio & Pharma
• Analysing the challenges and opportunities in translating cutting-edge discoveries into accessible and effective patient treatments
• Looking to the future – how can we use digital tech across the whole drug value chain?

Regulatory changes, especially those focused on emerging technologies, are increasingly impacting business models and compliance. This panel brings together experts to explore how companies can navigate this complex landscape. We'll delve into flexible approaches to policy development, such as regulatory sandboxes, outcome-based regulation, and adaptive regulation, and discuss strategies for managing the challenges of regulatory uncertainty and ensuring continued innovation.

• Strategies for managing the reduced speed of technology adoption, potential loss of investments, and increased compliance costs due to complex regulations
• Exploring how companies use technology to make sure they're following the rules, especially with data privacy
• How to proactively adapt to regulatory changes to avoid competitive disadvantages and capitalize on new opportunities

Imagine a future where clinical trials are seamlessly integrated into patients' lives, powered by intelligent technologies designed with human needs at their core. This session explores that future. We'll delve into the landscape of AI-powered, yet human-centred trials, examining how we rigorously validate these technologies before deployment. Join us as we explore AI's impact across all trial stages, address the critical need for unbiased algorithms, and discuss how AI can democratize access to trials for underserved communities. Discover how technology is reshaping clinical research to be more accessible, efficient, and patient-friendly

• What does the future of AI-powered but human centred clinical trials look like?
• How do we validate technologies before they get introduced into clinical trials?
• Exploring the use of AI in the various clinical trial stages
• How can we ensure that algorithms are unbiased and fair?
• Can AI help to improve access to clinical trials for underserved populations?

Precision medicine holds the promise of tailored treatments, driven by the power of AI and data. This panel explores the immense opportunities and significant challenges in realizing this vision. We'll delve into how AI and data analytics are transforming healthcare, while also addressing the critical barriers to widespread adoption and discussing strategies to overcome them.

• How can we effectively combine diverse data sources (genomic, clinical, lifestyle) to create comprehensive patient profiles for AI-driven precision medicine?
• What are the risks of bias in AI algorithms, and how can we ensure fairness, transparency, and patient trust in personalized medicine?
• Exploring how we bridge the gap between AI-generated insights and clinical implementation, ensuring that personalized treatments are accessible and effective for all patients?